Skip to main content

Marina Rigau Resina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Marina Rigau Resina

Marina Rigau Resina

Marina Rigau Resina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Validación de un perfil proteómico de biomarcadores en orina post-masaje prostático como predictor del riesgo y agresividad del càncer de próstata

IP: Joan Morote Robles
Collaborators: Inés de Torres Ramirez, Marina Rigau Resina
Funding agency: Fundación Investigación Urologia
Funding: 36000
Reference: FIU-2011-01
Duration: 23/08/2011 - 30/06/2013

Validació i comercialització d'un kit de diagnòstic precoç de càncer de pròstata en orina

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Marina Rigau Resina
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 76970.79
Reference: 2010 VALOR 00220
Duration: 13/01/2011 - 12/01/2013

Identificación de moléculas responsables de metástasis óseas en un modelo de ratones SCID humanizados

IP: -
Collaborators: José Placer Santos, Roberto Vélez Villa, Marina Rigau Resina
Funding agency: Instituto de Salud Carlos III
Funding: 96800
Reference: PI09/00496
Duration: 01/01/2010 - 31/12/2012

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Oncologia Translacional, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Berta Diaz Feijoo, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Marina Rigau Resina, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Albert Barberà LLuis

Albert Barberà LLuis

Director/a d'Àrea
External Strategy Directorate
Read more
Judit Amigó Farran

Judit Amigó Farran

Predoctoral researcher
Diabetes and Metabolism
Read more
Alba Rojano Toimil

Alba Rojano Toimil

Predoctoral researcher
Diabetes and Metabolism
Read more
Neus Mongay Ochoa

Neus Mongay Ochoa

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.